Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery

Table 1

Patient characteristics, hazard ratios, and values from univariable survival analysis ().

	(%)	Hazard ratio (95% CI)	value
Age (years)
<60	113 (52.6%)	Reference	—
≥60	102 (47.4%)	2.34 (1.23-4.46)	0.01
Sex
Male	167 (77.7%)	Reference	—
Female	48 (22.3%)	1.49 (0.75-2.94)	0.26
BMI (kg/m^2)		0.99 (0.89-1.11)	0.87
0-24	173 (80.5%)	Reference	—
>24	42 (19.5%)	0.73 (0.31-1.75)	0.48
Location
Upper	85 (39.5%)	Reference	—
Middle	38 (17.7%)	0.96 (0.40-2.31)	0.93
Lower	85 (39.5%)	0.73 (0.36-1.47)	0.38
Whole	7 (3.3%)	0.005 (0-10+)	0.72
Tumor grade
G3	151 (70.2%)	Reference	—
G2	56 (26%)	0.78 (0.38-1.62)	0.51
G1	8 (3.7%)	0.006 (0-10+)	0.65
Clinical T stage
cT3	109 (50.7%)	Reference	—
cT4	106 (49.3%)	1.61 (0.83-3.16)	0.16
Clinical N staging
cN0	5 (2.3%)	Reference	—
cN+	210 (97.7%)	1.61 (0.21-12.21)	0.645